726235

Gemini Pharmaceuticals, Inc. — FEI 2432926

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 1, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Commack, NY (United States)

Citations

IDCFRDescription
191821 CFR 211.166(a)(2)Stability sample storage conditions described
358521 CFR 211.110(a)Control procedures to monitor and validate performance